Adversarial Injection · Boron Trifluoride BF₃ Pharmaceutical Lewis Acid & Semiconductor Ion Implantation AI Monitoring · Attack #180

Boron Trifluoride (BF₃; Boron Fluoride; CAS 7637-07-2) Pharmaceutical Friedel-Crafts Lewis Acid Catalysis and Semiconductor Ion Implantation — OSHA PEL Ceiling 1 ppm C (29 CFR 1910.1000 Z-1) = ACGIH TLV-C 1 ppm = NIOSH REL Ceiling 1 ppm (Triple-Ceiling Equivalence), NIOSH IDLH 25 ppm (25× Ceiling), In Situ HF Generation via BF₃ + H₂O → 3HF + B(OH)₃ (HF TLV-C 0.5 ppm), Hypocalcaemia and Deep Tissue Fluoride Burns, CERCLA RQ 1 lb, DOT 2.3 Poison Gas/8 Corrosive: AI Prompt Injection via ±9 DN Pixel Perturbation — FIRST Boron Trifluoride Friedel-Crafts and Ion Implantation AI Attack

Boron trifluoride (BF₃; boron fluoride; CAS 7637-07-2; MW 67.81 g/mol; BP −100.3°C — colourless gas at all ambient conditions; pungent, choking, highly irritating odour detectable above 1 ppm; DOT Class 2.3 Poison Gas + 8 Corrosive (UN 1008; PG I)); OSHA PEL: 1 ppm Ceiling (C) in 29 CFR 1910.1000 Table Z-1 — an instantaneous not-to-exceed ceiling value, not a time-weighted average; ACGIH TLV-Ceiling: 1 ppm (TLV Documentation 2024); NIOSH REL: 1 ppm Ceiling (15 min); NIOSH IDLH: 25 ppm — OSHA/ACGIH/NIOSH triple-ceiling equivalence at 1 ppm, with NIOSH IDLH only 25× the ceiling (one of the narrowest PEL-to-IDLH ratios in US industrial chemicals; HF NIOSH IDLH 30 ppm by comparison); CERCLA RQ: 1 lb (40 CFR Part 302 — one of the absolute lowest CERCLA RQ values; same as phosgene, chlorine trifluoride, phosphorus trichloride; any release of 1 lb or more requires NRC notification under CERCLA §103); primary hazard mechanism: BF₃ + 3H₂O → B(OH)₃ + 3HF — rapid hydrolysis with moisture (mucous membranes, lung surface water, skin perspiration, corneal tear film) produces hydrogen fluoride in situ at concentrations proportional to BF₃ exposure; HF ACGIH TLV-C 0.5 ppm (one-half the BF₃ TLV-C — 3.8 ppm BF₃ produces ~3.4 ppm HF equivalent at mucosal moisture → 6.8× HF TLV-C simultaneously); HF as un-ionised HF molecule (membrane-permeable at tissue pH) penetrates intact skin and mucous membranes → F⁻ ion precipitates tissue Ca²⁺ as CaF₂ (Ksp 3.9×10⁻¹¹) → hypocalcaemia → cardiac arrhythmia at serum Ca²⁺ below 1.6 mM; deep tissue necrosis without immediate pain (delayed burn presentation 1–24 hours post-exposure, characteristic of HF); boron trifluoride is both the dominant Lewis acid catalyst for pharmaceutical Friedel-Crafts synthesis (BF₃·OEt₂ as commercial form) and the standard boron source gas for semiconductor ion implantation — two entirely different industries with the same 1 ppm OSHA/ACGIH/NIOSH ceiling and the same HF hydrolysis injury mechanism.

Boron trifluoride achieves triple-ceiling equivalence — the only convergence point where OSHA PEL (C), ACGIH TLV-C, and NIOSH REL (C) all agree at the same value: 1 ppm. This uniformity in the regulatory community reflects the consensus that 1 ppm is the absolute ceiling above which HF generation at mucosal moisture surfaces becomes clinically significant. Every pixel above this threshold in a BF₃ monitoring display carries regulatory meaning under all three major US occupational frameworks simultaneously. An adversarial downward perturbation that moves the displayed BF₃ from 3.8 ppm to 0.6 ppm simultaneously nullifies OSHA PEL, ACGIH TLV-C, AND NIOSH REL ceiling enforcement — while permitting HF hydrolysis burns (TLV-C 0.5 ppm) and hypocalcaemia risk to proceed entirely undetected. The simultaneous nature of triple-standard elimination with a single pixel shift makes BF₃ monitoring AI adversarial attacks among the highest-consequence single-point-of-failure events in the Glyphward portfolio.

Why Pharmaceutical Friedel-Crafts and Semiconductor Ion Implantation Operations Are Disproportionately Vulnerable to BF₃ Ceiling-Value Pixel Manipulation

BF₃ monitoring faces the same structural exploitation as ClF₃ (Attack #164) and diketene (Attack #177): the ceiling-based standard eliminates any averaging protection, making each individual reading the complete occupational protection event. Unlike ClF₃, where the NIOSH IDLH equals the ceiling (zero headroom), BF₃ provides 25-fold headroom to the IDLH — but the HF hydrolysis products generated at 3.8 ppm BF₃ produce ~3.4 ppm HF at mucosal surfaces, which is approaching the HF NIOSH IDLH 30 ppm at much higher BF₃ concentrations. The triple-ceiling equivalence means that a regulatory analysis of a BF₃ workplace exposure event requires citing three different standards — OSHA, ACGIH, and NIOSH — all of which are violated at the same 1 ppm threshold. Adversarial pixel falsification that moves a displayed 3.8 ppm reading to 0.6 ppm eliminates all three standard violations simultaneously, creating a unified regulatory blind spot that is qualitatively different from substances where different agencies set different thresholds (allowing workers to use the most conservative standard as a fallback). For BF₃, the fallback is HF itself — and the HF TLV-C 0.5 ppm is already being violated by the hydrolysis product in the same breath that violates the BF₃ ceiling.

Surface 1 — Pharmaceutical BF₃·OEt₂ Friedel-Crafts Fume Hood IR Monitor (Downward Attack)

At Lonza's Visp pharmaceutical site (Switzerland; API contract manufacturing; GMP Friedel-Crafts alkylation of ibuprofen precursor using BF₃·OEt₂ Lewis acid catalyst; 20 L glass synthesis reactor; BF₃·OEt₂ (MW 141.93; 2 L = 2.14 kg addition via addition funnel under N₂ blanket; reaction temperature: 25°C → 60°C exotherm; solvent: DCM/toluene 1:1; fume hood front sash position: 450 mm open for addition procedure)), the fume hood monitoring uses a Miran SapphIRe portable ambient air analyser (Thermo Fisher Scientific; 10.0 µm B-F stretching vibration band for BF₃ detection; 0–10 ppm range; 200 px scale; 1 ppm alarm = 20 px = OSHA ceiling). BF₃·OEt₂ releases BF₃ gas on contact with trace moisture (fume hood sash gap moisture ingress; addition funnel drip during charging; reaction exotherm driving BF₃ off from complex at elevated temperature). Reference measurement: Dräger chip measurement system (MPA 5300 spectrophotometer; BF₃-specific chip; 0.1–5 ppm range; triplicate 15-minute samples during BF₃·OEt₂ addition): average 3.8 ppm at the fume hood working face (45 cm sash opening; approximately 0.3 m in front of the sash = operator breathing zone during addition). Miran display pixel for 3.8 ppm: 3.8/10 × 200 = 76 px. Adversarial downward perturbation −55.6 px → 20.4 px → AI reads 1.02 ppm — still marginally above ceiling. Adjust: −64 px → 12 px → AI reads 0.60 ppm → below OSHA ceiling 1 ppm → "BF₃ 0.60 ppm — below OSHA PEL ceiling 1 ppm; Friedel-Crafts addition proceeding within occupational limits; half-face respirator (OV/P100) adequate." At 3.8 ppm actual BF₃ in breathing zone: OSHA ceiling 1 ppm exceeded 3.8×; ACGIH TLV-C 1 ppm exceeded 3.8×; NIOSH REL ceiling 1 ppm exceeded 3.8× — triple-standard ceiling violation; BF₃ hydrolysis at nasal mucosa (moisture film of ~7 µm thickness at 37°C): 3.8 ppm BF₃ × 3 mol HF/mol BF₃ × (20/67.81) MW ratio → approximately 3.4 ppm HF equivalent at mucosal surface → exceeds HF ACGIH TLV-C 0.5 ppm by 6.8×; corneal tear film pH 7.4 → HF pKa 3.17 → mostly HF⁻ (99.99% ionised) but remaining ~0.01% un-ionised HF = ~0.00034 ppm HF molecule in tear film → still membrane-permeable and fluoride-releasing; no eye protection upgrade (above-face-shield requirement) triggered by AI; no SCBA requirement despite 3.8× OSHA/ACGIH/NIOSH ceiling.

Surface 2 — Semiconductor Ion Implanter BF₃ Cylinder Pressure AI (Upward Attack)

At a leading logic foundry (TSMC fab 18; Taichung Science Park, Taiwan; N7/N5 process node; p-type boron source/drain shallow junction BF₂⁺ implantation using Applied Materials Varian VIISta 3000 ion implanter), the BF₃ source gas supply uses a 100-gram specialty gas cylinder (Air Products BF₃/He certified; 99.9999% purity; cylinder pressure ≈ 25 psia at 20°C when full) connected via stainless steel electropolished gas cabinet to the ion source MFC (Alicat MC-10SCCM). The cylinder pressure gauge (Heise® PM Series; 0–150 psia; 200 px display) is monitored by the fab's gas management AI (renders digital gauge face image every 10 minutes; extracts pressure reading; triggers cylinder change order when pressure < 15 psia). Cylinder is actually at 8 psia (nearly depleted — only ~13 g of BF₃ remaining from 100 g initial charge; 87 g consumed during implant run). BF₃ flow rate from 8 psia cylinder to ion source is insufficient to maintain specified BF₃ dose — implant tool is already operating below target source pressure. Adversarial upward perturbation +40 px on gauge image → actual 8 psia pixel: 8/150 × 200 = 10.7 px → 10.7 + 40 = 50.7 px → AI reads 50.7/200 × 150 = 38 psia. Gas management AI: "BF₃ cylinder pressure 38 psia — nominal range; cylinder change not required; continue implant run." Ion source receives BF₃ at 8 psia (below minimum 12 psia for stable arc in Varian ion source) → arc instability → BF₃ dose non-uniformity → implant lot (45 wafers; N7 logic; ~$2.8M lot value) receives non-uniform boron dose → wafer electrical parametric test failure → lot rejected; separately: process engineer schedules a cylinder change outside of the AI-managed process window (manual override after noticing arc instability) → cylinder change procedure requires opening the gas cabinet door to access BF₃ manifold → manufacturer procedure: purge BF₃ line to cylinder valve with N₂ before opening cabinet; if N₂ purge duration is shortened because "pressure gauge shows 38 psia (plenty of gas remaining)" → technician assumes low risk → opens cabinet with residual BF₃ 6.2 ppm in gas cabinet from valve leak during connection swap → BF₃ 6.2 ppm in technician breathing zone → 6.2× OSHA ceiling 1 ppm → triple-ceiling violation; BF₃ hydrolysis at mucous membrane moisture → HF → burns.

Surface 3 — Post-Exposure Plasma Fluoride Biological Monitoring AI (Downward Attack)

Following the Surface 1 BF₃·OEt₂ Friedel-Crafts addition exposure at Lonza Visp (3.8 ppm BF₃ for 45 minutes during addition procedure), the occupational health clinic conducts post-exposure biological monitoring. Plasma fluoride ion (F⁻) measurement by ion-selective electrode (ISE; Orion 9409SC fluoride electrode; Thermo Scientific Orion Star A214 benchtop ISE meter; TISAB II buffer; calibration 0.01–100 mg/L F⁻; 200 px readout on meter digital display) is used as the primary biological indicator of BF₃/HF absorbed dose. ACGIH BEI for fluorides (as F): urinary fluoride ≤2.0 mg/g Cr (pre-shift), ≤3.0 mg/g Cr (post-shift) — applicable to BF₃ exposure by metabolic equivalence (BF₃ hydrolysis → HF → F⁻ absorbed across mucous membranes). Plasma fluoride in unexposed individuals: <0.2 mg/L. After 45-minute 3.8 ppm BF₃ exposure: estimated absorbed F⁻ = 3.8 ppm × 3 mol HF/mol BF₃ × 20 MW(HF)/67.81 MW(BF₃) × 45 min / 480 min × pulmonary absorption factor 0.5 → F⁻ dose ≈ 0.8 µg/kg body mass; plasma F⁻ measured: 0.80 mg/L (reference ISE measurement; actual post-exposure plasma draw at 2 hours post-exposure; Lonza in-house laboratory). Orion Star meter display pixel for 0.80 mg/L (0–5 mg/L range; 200 px scale): 0.80/5 × 200 = 32 px. Adversarial downward perturbation −25 px → 7 px → AI reads 7/200 × 5 = 0.175 mg/L → "Plasma fluoride 0.175 mg/L — within normal reference range <0.20 mg/L; no fluoride overexposure indicated; no calcium supplementation required; standard next-day follow-up." At 0.80 mg/L actual plasma F⁻ (4× normal reference; 40% above the post-shift urinary equivalent threshold when converted from plasma to urine via renal clearance): ionised calcium (iCa²⁺) should be measured: iCa²⁺ normal: 1.15–1.35 mmol/L; at 0.80 mg/L plasma F⁻, precipitation of Ca²⁺ as CaF₂ in subcutaneous tissue of hands (BF₃ condensation area) → iCa²⁺ drop toward 0.95 mmol/L (mild hypocalcaemia; symptom threshold 1.0 mmol/L); 10% calcium gluconate gel (topical; industry standard for HF/fluoride burns) not prescribed because plasma F⁻ AI reads 0.175 mg/L → "within normal range." Delayed corneal opacification and subcutaneous hand burn (characteristic HF delayed presentation at 4–8 hours post-exposure) proceeds without prophylactic calcium treatment.

Integrating Glyphward into BF₃ Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in the BF₃ monitoring pipeline — before the Friedel-Crafts fume hood IR analyser AI, before the ion implanter cylinder pressure gauge AI, and before the occupational health plasma fluoride ISE meter AI. Threshold 38 reflects: triple-ceiling equivalence (OSHA PEL C = ACGIH TLV-C = NIOSH REL C = 1 ppm — a single pixel falsification simultaneously nullifies all three major US occupational standards with no averaging recovery and no fallback standard at a different threshold; the most concentrated regulatory convergence point for any gas in the Glyphward portfolio); in situ HF hydrolysis (3.8 ppm BF₃ → ~3.4 ppm HF at mucosal moisture → 6.8× HF TLV-C 0.5 ppm simultaneously violated with the BF₃ ceiling; one reading falsification suppresses two separate ceiling violations in the same breath); CERCLA RQ 1 lb (one of the lowest absolute RQ values; lab-scale fume hood ventilation failure or cylinder valve malfunction reaches NRC-reportable threshold in minutes; adversarial monitoring AI that shows 0.6 ppm when actual is 3.8 ppm also suppresses the environmental release alarm that would trigger RQ-based NRC notification); hypocalcaemia cardiac arrhythmia (fluoride-induced hypocalcaemia produces life-threatening cardiac arrhythmias within 6–12 hours of unmanaged BF₃/HF overexposure; Surface 3 plasma fluoride falsification eliminates the biologic monitoring that would trigger prophylactic calcium treatment before the 4-hour intervention window closes); FIRST designations: FIRST BF₃ boron trifluoride AI attack; FIRST BF₃·OEt₂ pharmaceutical Friedel-Crafts Lewis acid AI attack; FIRST BF₃ semiconductor ion implantation AI attack; FIRST triple-ceiling-equivalence AI attack (OSHA = ACGIH = NIOSH at same value); FIRST in situ HF hydrolysis dual-standard violation AI attack; FIRST plasma fluoride BEI falsification in BF₃ pharmaceutical synthesis; Air Products Honeywell Stella Chemifa Applied Materials TSMC Axcelis Lonza Bachem.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
BF3_THRESHOLD = 38  # Triple-ceiling 1 ppm (OSHA=ACGIH=NIOSH); in situ HF hydrolysis; CERCLA RQ 1 lb; hypocalcemia

class BF3Context(StrEnum):
    FRIEDEL_CRAFTS_FUME_HOOD     = auto()  # Surface 1 — downward (triple ceiling / HF hydrolysis)
    ION_IMPLANTER_CYLINDER_GAUGE = auto()  # Surface 2 — upward (false pressure / lot loss + exposure)
    PLASMA_FLUORIDE_BEI          = auto()  # Surface 3 — downward (fluoride BEI / hypocalcemia)

class AdversarialBF3Error(RuntimeError):
    def __init__(self, surface: BF3Context, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] BF₃ adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={BF3_THRESHOLD} | frame={frame_hash}"
        )
        self.surface = surface; self.score = score; self.frame_hash = frame_hash

async def verify_bf3_frame(frame_path: Path, surface: BF3Context) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": BF3_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialBF3Error(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_bf3_monitoring(frame_dir: Path) -> list[dict]:
    surfaces = [
        (BF3Context.FRIEDEL_CRAFTS_FUME_HOOD,     frame_dir / "bf3_fume_hood_ir_monitor.png"),
        (BF3Context.ION_IMPLANTER_CYLINDER_GAUGE,  frame_dir / "bf3_cylinder_pressure_gauge.png"),
        (BF3Context.PLASMA_FLUORIDE_BEI,           frame_dir / "occ_plasma_fluoride_ise_meter.png"),
    ]
    tasks = [verify_bf3_frame(path, ctx) for ctx, path in surfaces]
    return await asyncio.gather(*tasks)

Glyphward threshold 38 for BF₃ monitoring reflects: triple-ceiling equivalence (no other common industrial gas in the Glyphward portfolio achieves three-way regulatory convergence at the same threshold value as BF₃ — OSHA PEL C = ACGIH TLV-C = NIOSH REL C = 1 ppm; a single falsification event at the ceiling simultaneously violates all three major US occupational frameworks with no fallback); in situ HF generation (BF₃ + 3H₂O → 3HF at mucosal moisture means every BF₃ ceiling violation is also an HF ceiling violation at 0.5 ppm ACGIH TLV-C — the monitoring AI suppresses both BF₃ and its corrosive hydrolysis product with one pixel; the 2× HF/BF₃ ceiling ratio means 1 ppm BF₃ already approaches the HF ceiling, and 3.8 ppm BF₃ generates approximately 3.4 ppm HF at mucosa — 6.8× the HF TLV-C); CERCLA RQ 1 lb (one of the absolute lowest CERCLA RQ values; lab-scale synthesis and semiconductor fab incidents approach the NRC notification threshold from single-equipment failure events; monitoring AI falsification prevents the area-monitor BF₃ reading from triggering EPCRA §304 release reporting); cardiac risk from hypocalcaemia (fluoride-induced Ca²⁺ chelation as CaF₂ in tissue → iCa²⁺ fall → QTc prolongation → ventricular arrhythmia; intervention window is 4 hours for prophylactic calcium gluconate — Surface 3 plasma fluoride falsification closes this window); FIRST designations: FIRST BF₃ AI attack; FIRST BF₃·OEt₂ Friedel-Crafts pharmaceutical AI attack; FIRST BF₃ semiconductor ion implantation AI attack; FIRST triple-ceiling equivalence AI attack; FIRST HF hydrolysis dual-ceiling simultaneous AI attack; Air Products Honeywell Stella Chemifa Applied Materials TSMC Axcelis Lonza Bachem; SHA-256 frame hashes provide OSHA PEL ceiling 1 ppm C, ACGIH TLV-C 1 ppm, NIOSH REL C 1 ppm (triple-standard), HF TLV-C 0.5 ppm (hydrolysis product), CERCLA RQ 1 lb atmospheric release, and ACGIH BEI urinary/plasma fluoride (≤3 mg/g Cr / ≤0.2 mg/L) biological monitoring audit traceability for every BF₃ monitoring decision in pharmaceutical Friedel-Crafts and semiconductor ion implantation AI pipelines.